Research
Cellular
Both intermittent fasting (IF) and ketogenic diet (KD) independently show clinically significant benefits in improving metabolic parameters in metabolic syndrome (MetS) and type 2 diabetes (T2D), including reductions in HbA1c, fasting glucose, body weight, and triglycerides.
Practitioners may consider IF and KD as effective dietary interventions for managing MetS and T2D.
StrongSupportsmedium confidence
Both IF and KD independently show clinically significant benefits in improving metabolic parameters in MetS and T2D, including reductions in HbA1c, fasting glucose, body weight, and triglycerides.
Why this rating
The claim is based on a narrative review of recent scientific literature.
Source
The role of intermittent fasting and ketogenic diet in metabolic syndrome and type 2 diabetes
Charlotte Delrue et al. · Acta Clinica Belgica · 2025
reviewCited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →